首页> 美国卫生研究院文献>Biochemical Journal >Binding of rat chylomicrons and their remnants to the hepatic low-density-lipoprotein receptor and its role in remnant removal.
【2h】

Binding of rat chylomicrons and their remnants to the hepatic low-density-lipoprotein receptor and its role in remnant removal.

机译:大鼠乳糜微粒及其残余物与肝低密度脂蛋白受体的结合及其在残余物清除中的作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Binding and uptake of rat chylomicrons of different metabolic stages by the hepatic low-density-lipoprotein (LDL) receptor were studied. Pure chylomicrons, characterized by apolipoprotein B-48 devoid of contaminating B-100, were labelled in their cholesteryl esters. Lymph chylomicrons and serum chylomicrons, enriched in apolipoprotein E and the C-apolipoproteins, bound poorly to rat hepatic membranes. In contrast, chylomicron remnants, containing the apolipoproteins B-48 and E, bound with high affinity. Specific binding of remnants was virtually completely competed for by LDL free of apolipoprotein E. In addition, in ligand blots both remnants and LDL associated with the same protein with an Mr characteristic of the LDL receptor. Uptake of remnants during a single pass through isolated perfused rat livers was decreased to about 50% by an excess of LDL. It is concluded that rat chylomicron remnants are a ligand of the hepatic LDL receptor. The much higher affinity as compared with LDL is mediated by apolipoprotein E but not B-48, and is inhibited by the C-apolipoproteins. This explains why serum chylomicrons are not taken up by the liver, whereas remnants are rapidly removed from the circulation. Results from experiments in vivo suggest that the LDL receptor makes an important contribution to the hepatic uptake of remnants and may be the principal binding site of the liver responsible for remnant removal.
机译:研究了肝脏低密度脂蛋白(LDL)受体对不同代谢阶段大鼠乳糜微粒的结合和吸收。纯的乳糜微粒在其胆固醇酯中标记为无载脂蛋白B-100的载脂蛋白B-48。富含载脂蛋白E和C-载脂蛋白的淋巴乳糜微粒和血清乳糜微粒与大鼠肝膜结合不良。相反,含有载脂蛋白B-48和E的乳糜微粒残留物以高亲和力结合。残基的特异性结合实际上被不含载脂蛋白E的LDL完全竞争。此外,在配体印迹中,残基和LDL与具有LDL受体特征的同一蛋白相关。通过过量的低密度脂蛋白(LDL)将单次通过离体的灌注大鼠肝脏时的残留摄入量降低至约50%。结论是大鼠乳糜微粒残余物是肝LDL受体的配体。与LDL相比,亲和力高得多,是由载脂蛋白E介导的,而不是由B-48介导的,并且被C-载脂蛋白抑制。这解释了为什么血清乳糜微粒不会被肝脏吸收,而残留物会迅速从循环中清除。体内实验的结果表明,LDL受体对肝脏对残留物的吸收有重要贡献,并且可能是负责残留物清除的肝脏的主要结合位点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号